⚠ FOR RESEARCH USE ONLY • Not for human or animal consumption • Not intended to diagnose, treat, cure, or prevent any disease • Read full disclaimer
£0.00
This product is intended strictly for laboratory research and in-vitro studies.
NOT FOR HUMAN OR ANIMAL CONSUMPTIONS.
Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm you are a qualified researcher or laboratory professional.
✓ CoA Verified
Original price was: £230.00.£200.00Current price is: £200.00.
Product Name: KLOW
Blend Components: GHK-Cu (50mg) / KPV (10mg) / BPC-157 (10mg) / TB-500 (10mg)
Research Category: Multi-Peptide / Cellular & Tissue Biology Research Blend
Compound Type: Four-Component Research Peptide Formulation
Research Interest: Extracellular matrix biology, inflammatory signaling, cellular migration, collagen-associated pathways, cytoskeletal biology, angiogenesis research, and tissue-remodeling mechanisms.
GHK-Cu – 50mg: A copper-binding tripeptide composed of glycyl-L-histidyl-L-lysine complexed with copper. GHK-Cu is investigated in research involving extracellular matrix regulation, collagen-associated pathways, fibroblast activity, cellular signaling, and tissue remodeling.
KPV – 10mg: A short tripeptide with the amino-acid sequence Lys-Pro-Val (KPV), derived from the C-terminal region of alpha-melanocyte-stimulating hormone (α-MSH). KPV is studied primarily in experimental research involving inflammatory signaling, immune-cell responses, epithelial biology, and cellular regulatory pathways.
BPC-157 – 10mg: A synthetic 15-amino-acid peptide investigated primarily in preclinical models. Research has explored its relationship with cellular migration, angiogenesis-associated signaling, gastrointestinal tissue biology, inflammatory responses, and tissue-remodeling pathways.
TB-500 – 10mg: A research peptide associated with thymosin beta-4-related biological pathways. Research involving this class of peptides focuses on actin-associated cytoskeletal processes, cellular migration, angiogenesis, and tissue-remodeling mechanisms.
KLOW is a four-component research blend combining GHK-Cu, KPV, BPC-157, and TB-500. The individual components are investigated across different experimental pathways involving extracellular matrix biology, inflammatory signaling, cellular migration, cytoskeletal regulation, and tissue-remodeling processes.
The components of KLOW are studied through distinct but potentially related biological pathways. GHK-Cu is associated with copper-dependent signaling and extracellular matrix biology. KPV is investigated for its interaction with inflammatory and cellular signaling pathways. BPC-157 research focuses on cellular and vascular signaling, while TB-500-related research examines actin-associated cytoskeletal activity and cellular migration.
Experimental research involving these compounds includes extracellular matrix and collagen biology, fibroblast activity, inflammatory signaling, epithelial biology, cellular migration, cytoskeletal regulation, angiogenesis-associated pathways, and tissue-remodeling mechanisms. Evidence and characterization vary considerably between the individual components.
Storage requirements depend on the exact formulation and supplier. Research material should be stored according to the accompanying certificate of analysis (COA), product specification sheet, and manufacturer instructions.
KLOW contains investigational research peptides. Information provided here is for scientific and research reference purposes only and should not be interpreted as medical, prescribing, or dosing advice.
Complete Your Stack
Researchers who bought this also added
Your Stack